Autonomous lab-on-paper for multiplexed, CRISPR-based diagnostics of SARS-CoV-2.

Lab on a Chip
Kun YinChangchun Liu

Abstract

The COVID-19 pandemic, caused by severe acute respiratory coronavirus 2 (SARS-CoV-2), has become a public health emergency and widely spread around the world. Rapid, accurate and early diagnosis of COVID-19 infection plays a crucial role in breaking this pandemic. However, the detection accuracy is limited for current single-gene diagnosis of SARS-CoV-2. Herein, we develop an autonomous lab-on-paper platform for multiplex gene diagnosis of SARS-CoV-2 by combining reverse transcription recombinase polymerase amplification (RT-RPA) and CRISPR-Cas12a detection. The autonomous lab-on-paper is capable of simultaneously detecting nucleoprotein (N) gene and spike (S) gene of SARS-CoV-2 virus as well as human housekeeping RNAse P gene (an internal control) in a single clinical sample. With the developed platform, 102 copies viral RNA per test can be detected within one hour. Also, the lab-on-paper platform has been used to detect 21 swab clinical samples and obtains a comparable performance to the conventional RT-PCR method. Thus, the developed lab-on-paper platform holds great potential for rapid, sensitive, reliable, multiple molecular diagnostics of COVID-19 and other infectious diseases in resource-limited settings.

References

Mar 8, 2011·Trends in Biotechnology·Angelika NiemzDavid S Boyle
Nov 16, 2013·Analytical Chemistry·Jared HoughtalingElain Fu
Apr 15, 2017·Science·Jonathan S GootenbergFeng Zhang
Oct 27, 2017·The New England Journal of Medicine·Angela M Caliendo, Richard L Hodinka
Apr 28, 2018·Science·Daniel S Chertow
May 1, 2018·Cell Discovery·Shi-Yuan LiJin Wang
Jan 19, 2019·Trends in Biotechnology·Yi LiGuozhen Liu
Feb 23, 2020·JAMA : the Journal of the American Medical Association·Yan BaiMeiyun Wang
Feb 28, 2020·JAMA : the Journal of the American Medical Association·Lan LanHaibo Xu
Mar 4, 2020·JAMA : the Journal of the American Medical Association·C Jason WangRobert H Brook
Apr 17, 2020·Expert Review of Molecular Diagnostics·Alireza Tahamtan, Abdollah Ardebili
Jul 1, 2020·Nature·Enrico LavezzoUNKNOWN Imperial College COVID-19 Response Team
Jul 12, 2020·Nature Microbiology·Chantal B F VogelsNathan D Grubaugh
Jul 29, 2020·Science Translational Medicine·Viet Loan Dao ThiSimon Anders

❮ Previous
Next ❯

Citations

Oct 9, 2021·Advanced Materials·Zhaowei ZhangUtkan Demirci
Nov 16, 2021·Lab on a Chip·Harshit HarpaldasSamuel K Sia

❮ Previous
Next ❯

Methods Mentioned

BETA
Fluorescence
fluorescence imaging
PCR

Software Mentioned

Image J
SolidWorks

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.